120 related articles for article (PubMed ID: 27764753)
1. Inactivation of transforming growth factor-β-activated kinase 1 promotes taxol efficacy in ovarian cancer cells.
Bo L; Cui H; Fang Z; Qun T; Xia C
Biomed Pharmacother; 2016 Dec; 84():917-924. PubMed ID: 27764753
[TBL] [Abstract][Full Text] [Related]
2. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
[TBL] [Abstract][Full Text] [Related]
3. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway.
Zhang L; Fu Z; Li X; Tang H; Luo J; Zhang D; Zhuang Y; Han Z; Yin M
Chem Biol Drug Des; 2017 Sep; 90(3):450-455. PubMed ID: 28224764
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1.
Ying L; Chunxia Y; Wei L
Cancer Chemother Pharmacol; 2015 Sep; 76(3):641-50. PubMed ID: 26228528
[TBL] [Abstract][Full Text] [Related]
6. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.
Guan S; Lu J; Zhao Y; Woodfield SE; Zhang H; Xu X; Yu Y; Zhao J; Bieerkehazhi S; Liang H; Yang J; Zhang F; Sun S
Oncotarget; 2017 May; 8(20):33666-33675. PubMed ID: 28430599
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of hyperthermia-induced apoptosis by 5Z-7-oxozeaenol, a TAK1 inhibitor, in A549 cells.
Li P; Zhao QL; Jawaid P; Rehman MU; Sakurai H; Kondo T
Cell Stress Chaperones; 2016 Sep; 21(5):873-81. PubMed ID: 27448221
[TBL] [Abstract][Full Text] [Related]
8. Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer.
Huang HL; Chiang CH; Hung WC; Hou MF
Oncotarget; 2015 Jan; 6(2):995-1007. PubMed ID: 25557171
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer.
Brouwer-Visser J; Lee J; McCullagh K; Cossio MJ; Wang Y; Huang GS
PLoS One; 2014; 9(6):e100165. PubMed ID: 24932685
[TBL] [Abstract][Full Text] [Related]
10. Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.
Cai PC; Shi L; Liu VW; Tang HW; Liu IJ; Leung TH; Chan KK; Yam JW; Yao KM; Ngan HY; Chan DW
Oncotarget; 2014 Sep; 5(17):7549-62. PubMed ID: 25277189
[TBL] [Abstract][Full Text] [Related]
11. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy.
Fan Y; Cheng J; Vasudevan SA; Patel RH; Liang L; Xu X; Zhao Y; Jia W; Lu F; Zhang H; Nuchtern JG; Kim ES; Yang J
Apoptosis; 2013 Oct; 18(10):1224-34. PubMed ID: 23700229
[TBL] [Abstract][Full Text] [Related]
12. Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade.
Choo MK; Kawasaki N; Singhirunnusorn P; Koizumi K; Sato S; Akira S; Saiki I; Sakurai H
Mol Cancer Ther; 2006 Dec; 5(12):2970-6. PubMed ID: 17172402
[TBL] [Abstract][Full Text] [Related]
13. Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.
Zhang J; Li B; Wu H; Ou J; Wei R; Liu J; Cai W; Liu X; Zhao S; Yang J; Zhou L; Liu S; Liang A
Tumour Biol; 2016 Jan; 37(1):531-9. PubMed ID: 26227222
[TBL] [Abstract][Full Text] [Related]
14. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
[TBL] [Abstract][Full Text] [Related]
15. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage.
Zhang D; Yan H; Li H; Hao S; Zhuang Z; Liu M; Sun Q; Yang Y; Zhou M; Li K; Hang C
J Biol Chem; 2015 Aug; 290(32):19900-9. PubMed ID: 26100626
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
17. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
[TBL] [Abstract][Full Text] [Related]
18. Live imaging of transforming growth factor-β activated kinase 1 activation in Lewis lung carcinoma 3LL cells implanted into syngeneic mice and treated with polyinosinic:polycytidylic acid.
Takaoka S; Kamioka Y; Takakura K; Baba A; Shime H; Seya T; Matsuda M
Cancer Sci; 2016 May; 107(5):644-52. PubMed ID: 26931406
[TBL] [Abstract][Full Text] [Related]
19. Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization.
Wang JH; Tseng CL; Lin FL; Chen J; Hsieh EH; Lama S; Chuang YF; Kumar S; Zhu L; McGuinness MB; Hernandez J; Tu L; Wang PY; Liu GS
Theranostics; 2022; 12(2):657-674. PubMed ID: 34976206
[No Abstract] [Full Text] [Related]
20. Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells.
Fan LL; Chen X; Zhang XY; Li ZM; Fan XM; Shen Y
Med Sci Monit; 2020 Aug; 26():e922612. PubMed ID: 32829374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]